Natus Medical Inc

Natus Medical, Inc. provides medical device solutions focuses on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. Its products are used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, sleep disorders, neuromuscular diseases and balance and mobility disorders. The company was founded by Maurizio Liverani, John Robert Camber Porter, William New, Jr., Brian Prinn and William W. Moore on May 26, 1987 and is headquartered in Middleton, WI.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Natus Medical, Inc. engages in providing healthcare solutions. It also focuses on the diagnosis and treatment of central nervous and sensory system disorders. The company was founded by Maurizio Liverani, John Robert Camber Porter, William Jr. New, Brian Prinn and William W. Moore on May 26, 1987 and is headquartered in Middleton, WI.

Hologic

IDEXX Laboratories

3 Top Medical Instruments Stocks to Beat COVID-19 Resurgence Crisis

Owens & Minor

Penumbra

Rocky Brands

Sturm, Ruger & Company

Low-beta stocks may be able to help sail through the choppy market conditions.

Buy These 5 Low-Beta Stocks & Combat the Choppy Market

Toyota Motor

To combat the choppy market conditions, it is of utmost importance to create a portfolio of low-beta stocks.

Buy These 5 Low-Beta Stocks to Beat the Choppy Market

Natus Medical Incorporated's (NTUS) CEO Jonathan Kennedy on Q4 2020 Results - Earnings Call Transcript

Natus Medical (NTUS) delivered earnings and revenue surprises of 62.50% and 0.18%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Natus Medical (NTUS) Tops Q4 Earnings and Revenue Estimates

PLEASANTON, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced financial results for the three months and full year ended December 31, 2020.

Natus Medical Announces Fourth Quarter 2020 Financial Results

Natus Medical (NASDAQ:NTUS) announces its next round of earnings this Thursday, February 25. Here is Benzinga's look at Natus Medical's Q4 earnings report.

A Preview Of Natus Medical's Earnings

PLEASANTON, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today updated fourth quarter 2020 revenue guidance (previously released October 29, 2020) and announced that Jonathan Kennedy, President and Chief Executive Officer will present at the virtual 39th Annual JP Morgan Healthcare Conference and virtual 23rd Annual Needham Growth Conference.

Natus Updates Fourth Quarter 2020 Revenue Guidance and Announces Investor Conference Attendance

PLEASANTON, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Company will release its 2020 fourth quarter financial results after the close of the market on Thursday, February 25th. Natus management will host a conference call the same day beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss those results and to answer questions.

Natus Medical to Hold 2020 Fourth Quarter Financial Results Conference Call on February 25th

PLEASANTON, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced that Drew Davies, Executive Vice President and Chief Financial Officer will present at the 13th Annual LD Micro Conference. Mr. Davies is scheduled to present on Monday, December 14th at 12:40 p.m. Eastern Time (9:40 a.m. Pacific Time).

Natus to Participate in 13th Annual LD Micro Conference

PLEASANTON, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced the acquisition of Babybe GmbH and its patented remote mother to baby communication technology. The Babybe technology will add to Natus's market leading Newborn Care portfolio of products.

Natus Medical Announces Acquisition of Innovative Newborn Care Technology

Natus Medical (NTUS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Earnings Estimates Moving Higher for Natus Medical (NTUS): Time to Buy?

Natus Medical (NTUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Natus Medical (NTUS) Moves to Buy: Rationale Behind the Upgrade

Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q3 2020 Results - Earnings Call Transcript

Natus Medical (NTUS) delivered earnings and revenue surprises of 800.00% and 8.90%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Natus Medical (NTUS) Q3 Earnings and Revenues Beat Estimates

PLEASANTON, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced financial results for the three and nine months ended September 30, 2020.

Natus Medical Announces Third Quarter 2020 Financial Results

Natus Medical (NTUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Natus Medical (NTUS) Q3 Earnings Expected to Decline

PLEASANTON, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Company will release its 2020 third quarter financial results after the close of the market on Thursday, October 29th. Natus management will host a conference call the same day beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss those results and to answer questions.

Natus Medical to Hold 2020 Third Quarter Financial Results Conference Call on October 29th

PLEASANTON, Calif., Sept.  08, 2020  (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced that Jonathan Kennedy, President and Chief Executive Officer and Drew Davies, Executive Vice President and Chief Financial Officer will be hosting one-on-one meetings with institutional investors at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference on Monday, September 14th. Investors interested in scheduling a meeting should contact a Morgan Stanley representative.

Natus to Participate in Morgan Stanley Virtual 18th Annual Global Healthcare Conference

Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q2 2020 Results - Earnings Call Transcript

Natus Medical (NTUS) delivered earnings and revenue surprises of -360.00% and -13.67%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Natus Medical (NTUS) Reports Q2 Loss, Lags Revenue Estimates

PLEASANTON, Calif., July  30, 2020  (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced financial results for the three and six months ended June 30, 2020.

Natus Medical Announces Second Quarter 2020 Financial Results

Analysts Estimate Natus Medical (NTUS) to Report a Decline in Earnings: What to Look Out for

PLEASANTON, Calif., June  11, 2020  (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced that Jonathan Kennedy, President and Chief Executive Officer and Drew Davies, Executive Vice President and Chief Financial Officer will be hosting one-on-one meetings with institutional investors at the Raymond James Virtual Human Health Innovation Conference on Tuesday, June 16th. Investors interested in scheduling a meeting should contact a Raymond James representative.

Natus to Participate in Raymond James Virtual Human Health Innovation Conference

What should investors think of this infant care and neurology specialist?

News for Natus Medical Inc Stock (NTUS)